TXMD Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 03, 2026
Report Source: 2025 Annual Report
TherapeuticsMD Inc. Stock Analysis TXMD
TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Read More TherapeuticsMD Inc (TXMD) Chart
Key Statistics of TherapeuticsMD Inc (TXMD)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$2.00Volume
9915.00P/E Ratio (TTM)
-52 Week Range
Market Cap
23.96MAvg. Volume
25.10KDividend Yield
-Financial Metrics & Statements of TherapeuticsMD Inc (TXMD)
FAQ's for TherapeuticsMD Inc (TXMD)
- According to Musaffa’s Shariah screening methodology, TherapeuticsMD Inc (TXMD) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.